Literature DB >> 5814993

Evaluation of factors related to growth of Rift Valley fever virus in suspended cell cultures.

J S Walker, R C Carter, F Klein, S E Snowden, R E Lincoln.   

Abstract

The effect of several controlled variables on the peak titer and fold increase of Rift Valley fever virus grown in suspension culture on two variants of Earle's L cell, L-DR and L-MA clone 1-1, was studied. No significant amount of cell-associated virus was found at 24 hr, indicating a release of virus soon after its formation. Mild sonic treatment of the virus produced in serum-free medium increased the infective titer about 10x. This difference was not observed with virus produced in medium supplemented with serum. Peak titer was not affected by medium used during the infection period, by multiplicity of inoculum (MOI), or by initial cell concentration within the test range of 10(4) to 2 x 10(6) cell/ml. Cell strain employed influenced titer, because the L-DR cell did not produce virus efficiently at low MOI and low initial cell concentration. The time of peak titer and fold replication was dependent on MOI and initial cell concentration. Differences in virus propagation in monolayer and suspension systems are discussed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5814993      PMCID: PMC377775          DOI: 10.1128/am.17.5.658-664.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  Virus particle adsorption. II. Adsorption of vaccinia and fowl plague viruses to cells in suspension.

Authors:  A C ALLISON; R C VALENTINE
Journal:  Biochim Biophys Acta       Date:  1960-06-03

2.  Multiplication of Rift Valley fever virus in human liver cell culture with special reference to production complement fixing antigen.

Authors:  S IWASA
Journal:  Jpn J Exp Med       Date:  1959-08

3.  Tissue culture techniques and their application to original isolation, growth, and assay of poliomyelitis and orphan viruses.

Authors:  J L MELNICK
Journal:  Ann N Y Acad Sci       Date:  1955-09-27       Impact factor: 5.691

4.  Propagation of Rift Valley fever virus in ascites hepatoma cells of the rat: production of a new variant of the virus.

Authors:  N TAKEMORI; M NAKANO; M HEMMI; M KITAOKA
Journal:  Virology       Date:  1955-05       Impact factor: 3.616

5.  Plaque formation with Rift Valley fever virus.

Authors:  N TAKEMORI; M NAKANO; M HEMMI
Journal:  Virology       Date:  1955-07       Impact factor: 3.616

6.  Destruction of tumour cells by Rift Valley fever virus.

Authors:  N TAKEMORI; M NAKANO; M HEMMI; H IKEDA; S YANAGIDA; M KITAOKA
Journal:  Nature       Date:  1954-10-09       Impact factor: 49.962

7.  A precise method for replicating suspension cultures of mammalian cells.

Authors:  F J Weirether; J S Walker; R E Lincoln
Journal:  Appl Microbiol       Date:  1968-06

Review 8.  Rift valley fever.

Authors:  B C Easterday
Journal:  Adv Vet Sci       Date:  1965

9.  Effect of virus input multiplicity and tissue cell concentration on growth of Rift Valley fever virus.

Authors:  M D Orlando; R D DeLauter; J M Riley
Journal:  Appl Microbiol       Date:  1967-05

10.  Biological characteristics of plaque variants of Rift Valley fever virus.

Authors:  J J Boyle
Journal:  Am J Vet Res       Date:  1967-07       Impact factor: 1.156

  10 in total
  3 in total

1.  Adaptation of BHK-21 cells to growth in shaker culture and subsequent challenge by Japanese encephalitis virus.

Authors:  L E Guskey; H M Jenkin
Journal:  Appl Microbiol       Date:  1975-09

2.  Concentration of Rift Valley fever and Chikungunya viruses by precipitation.

Authors:  F Klein; B G Mahlandt; R R Cockey; R E Lincoln
Journal:  Appl Microbiol       Date:  1970-09

3.  Creation of a recombinant Rift Valley fever virus with a two-segmented genome.

Authors:  Benjamin Brennan; Stephen R Welch; Angela McLees; Richard M Elliott
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.